SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-060168
Filing Date
2021-11-17
Accepted
2021-11-16 20:43:28
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_biotechacqu.htm   iXBRL 10-Q 748633
2 CERTIFICATION f10q0921ex31-1_biotech.htm EX-31.1 11807
3 CERTIFICATION f10q0921ex31-2_biotech.htm EX-31.2 11213
4 CERTIFICATION f10q0921ex32-1_biotech.htm EX-32.1 4201
5 CERTIFICATION f10q0921ex32-2_biotech.htm EX-32.2 4345
  Complete submission text file 0001213900-21-060168.txt   3955208

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE biot-20210930.xsd EX-101.SCH 50199
7 XBRL CALCULATION FILE biot-20210930_cal.xml EX-101.CAL 22114
8 XBRL DEFINITION FILE biot-20210930_def.xml EX-101.DEF 186915
9 XBRL LABEL FILE biot-20210930_lab.xml EX-101.LAB 355854
10 XBRL PRESENTATION FILE biot-20210930_pre.xml EX-101.PRE 194040
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_biotechacqu_htm.xml XML 551014
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39935 | Film No.: 211418134
SIC: 6770 Blank Checks